Article
Definitive N-terminal protein sequence and further characterization of the novel apolipoprotein A5 in human serum.
Clinical chemistry - 1 Mar 2006
Alborn William E, Johnson Melvin G, Prince Melvin J, Konrad Robert J
Abstract excerpt
BACKGROUND: Apolipoprotein A5 (ApoA5) originally gained attention as a regulator of serum triglyceride concentrations through transgenic mouse studies. Our group recently developed the first assay to quantify serum ApoA5 protein concentrations and demonstrated that they are increased by administration of a potent peroxisome proliferator-activated receptor-alpha agonist. METHODS: To better characterize the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
